CN109824592B - Dual-functional fluorescent probe intermediate for detecting formaldehyde and pH, and preparation method and application thereof - Google Patents
Dual-functional fluorescent probe intermediate for detecting formaldehyde and pH, and preparation method and application thereof Download PDFInfo
- Publication number
- CN109824592B CN109824592B CN201810582599.2A CN201810582599A CN109824592B CN 109824592 B CN109824592 B CN 109824592B CN 201810582599 A CN201810582599 A CN 201810582599A CN 109824592 B CN109824592 B CN 109824592B
- Authority
- CN
- China
- Prior art keywords
- compound
- formaldehyde
- fluorescence
- fluorescent probe
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 title abstract description 215
- 150000001875 compounds Chemical class 0.000 claims abstract description 122
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims abstract description 7
- 229910000024 caesium carbonate Inorganic materials 0.000 claims abstract description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 11
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000004440 column chromatography Methods 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000001588 bifunctional effect Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 85
- 239000000872 buffer Substances 0.000 description 30
- 239000000523 sample Substances 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 29
- 230000005284 excitation Effects 0.000 description 18
- 238000002189 fluorescence spectrum Methods 0.000 description 18
- 239000011550 stock solution Substances 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 8
- 238000003384 imaging method Methods 0.000 description 7
- 230000003834 intracellular effect Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 206010008342 Cervix carcinoma Diseases 0.000 description 5
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 5
- 201000010881 cervical cancer Diseases 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000008098 formaldehyde solution Substances 0.000 description 5
- 239000010413 mother solution Substances 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 108010024636 Glutathione Proteins 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 238000001506 fluorescence spectroscopy Methods 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 210000003712 lysosome Anatomy 0.000 description 3
- 230000001868 lysosomic effect Effects 0.000 description 3
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 2
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 2
- 108010062431 Monoamine oxidase Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 2
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical class C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a bifunctional fluorescent probe intermediate for detecting formaldehyde and pH, and a preparation method and application thereof. The intermediate is shown as a formula (IV), and the preparation method comprises the following steps: the compound (II) and the compound (III) generate a compound (IV) under the action of cesium carbonate. The invention provides application of a compound (IV) as an intermediate for preparing a fluorescent probe shown as a formula (I). The invention has the beneficial effects that the fluorescent probe intermediate is provided, the prepared fluorescent probe can simultaneously detect formaldehyde and pH in cells, and an effective research tool is provided for researching the physiological action of the formaldehyde and the pH in the cells.
Description
Technical Field
The invention relates to a bifunctional fluorescent probe intermediate for detecting formaldehyde and pH, and a preparation method and application thereof.
Background
1. Formaldehyde belongs to an activated carbon cluster and is a recognized carcinogen. Formaldehyde is derived from endogenous metabolites produced by intracellular oxidase and demethylase, and the concentration of formaldehyde in normal cells can reach about 0.4 mM. Excessive formaldehyde in the body can cause neurodegenerative diseases, alzheimer's disease, various cancers, and the like. However, most of the current formaldehyde detection methods cannot monitor the intracellular formaldehyde concentration in real time, and therefore, it is imperative to develop a novel fluorescent probe for detecting the intracellular formaldehyde.
2. pH and formaldehyde concentration levels are interdependent in physiological environments, pH affects formaldehyde production by altering the activity of lysine-specific demethylase, while FA and acidic microenvironment can synergistically induce bone cancer pain. Thus, simultaneous imaging of pH and formaldehyde in complex organisms would likely help to further understand the relationship between each other. In recent years, the development of fluorescent probes has been used for pH or formaldehyde imaging in living cells or tissues. However, no single probe can simultaneously image two analytes in the same system.
3. Fluorescent probes are receiving attention from researchers due to their advantages of high sensitivity, real-time detection, small biological damage, etc. The invention aims to develop a novel formaldehyde and pH fluorescent probe which can accurately detect the concentration and pH value of formaldehyde in cells.
Disclosure of Invention
The invention aims to provide an intermediate of a bifunctional fluorescent probe capable of detecting formaldehyde and pH.
The second purpose of the invention is to provide a preparation method of the intermediate.
The third purpose of the invention is to provide the application of the fluorescent probe intermediate in preparing the bifunctional fluorescent probe capable of detecting formaldehyde and pH.
The invention adopts the following technical scheme for realizing the purpose:
the invention provides a compound shown as a formula (IV):
a method for preparing a compound of formula (IV), comprising:
under the action of cesium carbonate, generating a compound (IV) by using a compound (II) and a compound (III);
further, the preparation method specifically comprises the following steps: compound (III), Cs2CO3Mixing the mixture in anhydrous DMF at a ratio of 1: 1-1.5 (preferably 1:1), adding compound (II) dropwise, and adding the mixture to N2Stirring overnight at 40-50 ℃ under protection; the solvent was removed under reduced pressure and the resulting residue was purified by silica column chromatography (preferably using ethyl acetate/petroleum ether in a volume ratio of 1:10 as eluent) to give compound (IV).
The compounds (II) of the present invention are disclosed, and their preparation is described in the literature (K.J.Bruemmer, R.R.Walvoord, T.F.Brewer, G.Burgos-Barragan, N.Wit, L.B.Pontel, K.J.Patel and C.J.Chang, Development of a General Aza-code Reaction Trigger Applied fluorine Imaging of formuladhesive in Living cells J.am.chem.Soc.,2017,139,5338.)
The compound (III) of the present invention is a disclosed compound, and its preparation method can be referred to in the literature (2.H.park, S. -K.Chang, signalling of water content in organic solvents by solvation of hydrochloric of a hydroxynaphthalene derivative-base heterocyclic dye. dyes and Pigments,2015,122,324.)
The invention further provides application of the compound (IV) as an intermediate for preparing the fluorescent probe shown in the formula (I);
specifically, the application is as follows: adding tin dichloride, triethylamine and thiophenol into an acetonitrile solvent according to the mass ratio of 1: 2-3.5 (preferably 1:3:3), stirring at 30-40 ℃ for 15-30 min, and then adding a compound (IV), wherein the mass ratio of the compound (IV) to tin dichloride dihydrate is 0.5-1: 1 (preferably 0.7: 1), and continuously stirring for 12 to 14 hours at the temperature of between 30 and 40 ℃; the reaction mixture was concentrated under reduced pressure and purified by silica column chromatography (preferably with ethyl acetate/petroleum ether in a volume ratio of 1:3 as the elution reagent) to give compound (I).
Further, the fluorescent probe shown in the formula (I) is used for detecting formaldehyde and/or pH concentration.
Further, the concentration of formaldehyde is preferably intracellular formaldehyde concentration, and the concentration is not higher than 1 mmol/L.
Further, the pH concentration is that of intracellular lysosomes, which ranges from 4.5 to 5.5.
Still further, the cell is human cervical cancer cell Hela cell.
The compound (I) provided by the invention is used as a fluorescent probe and can be applied to fluorescent quantitative detection of formaldehyde. The fluorescence detection principle of the quantitative formaldehyde concentration is as follows: after the compound (I) reacts with formaldehyde, a reactive group is removed to generate a fluorescent substance compound VII, and the change of the fluorescence intensity of the probe at an emission wavelength of 555nm is measured when the excitation is 455nm, so that the formaldehyde concentration is obtained.
The principle of detecting the concentration of formaldehyde by using the novel formaldehyde fluorescent probe is as follows:
the compound (I) provided by the invention is used as a fluorescent probe and can be applied to fluorescent quantitative detection of pH. The fluorescence detection principle for quantifying the pH concentration is as follows: after the compound (I) reacts with pH, an amino group is taken as a pH sensitive group to obtain a proton to form NH3 +The reaction group, the fluorescence intensity increased, and the change in fluorescence intensity of the probe at an emission wavelength of 455nm upon excitation at 365nm was measured, thereby obtaining the pH value. The principle of detecting pH concentration using the fluorescent probe of the present invention is as follows:
confocal fluorescence microscope imaging experiments well prove that the fluorescent probe disclosed by the invention can detect the change of the concentration of formaldehyde in cells and the acid-base environment in the cells, provides a new tool for researching the metabolic mechanism in the cells, and has a good prospect in the biological field.
Compared with the prior art, the invention provides the fluorescent probe intermediate, the prepared fluorescent probe can simultaneously detect formaldehyde and pH in cells, and an effective research tool is provided for researching the physiological action of the formaldehyde and the pH in the cells.
Drawings
FIG. 1 is a nuclear magnetic hydrogen spectrum of compound (I) prepared in example 1 of the present invention.
FIG. 2 shows a nuclear magnetic carbon spectrum of Compound (I) prepared in example 1 of the present invention.
Fig. 3 is a graph showing fluorescence absorption spectra of compound (I) prepared in example 1 of the present invention, when different equivalents of formaldehyde solution were added under the conditions of DMSO/PBS buffer (pH 7.4, v/v 1/199).
Fig. 4 is a graph showing fluorescence absorption spectra of compound (I) prepared in example 1 of the present invention in DMSO/PBS buffer solutions (v/v-1/199) at pH 3.5 and pH 7.5, respectively.
Fig. 5 shows fluorescence emission spectra of compound (I) prepared in example 1 of the present invention when different equivalents of formaldehyde solution were added under the conditions of DMSO/PBS buffer (pH 7.4, v/v 1/199). FIG. 5 excitation wavelength 455nm and emission wavelength 555 nm.
Fig. 6 is a fluorescence plot of compound (I) (0.5 μ M) prepared in example 1 of the present invention as a function of time during the action with formaldehyde (0.5mM) in DMSO/PBS buffer (pH 7.4, v/v 1/199). FIG. 6 excitation wavelength 455nm and emission wavelength 555 nm.
Fig. 7 is a fluorescence diagram of the selectivity results of compound (I) prepared in example 1 of the present invention in DMSO/PBS buffer (pH 7.4, v/v 1/199). 1-15 are PBS, acetaldehyde, benzaldehyde, p-nitrobenzaldehyde, p-hydroxybenzaldehyde, acetone, formic acid, glucose, glutathione, homocysteine, cysteine, sodium bisulfate, hydrogen peroxide, tert-butyl hydroperoxide and formaldehyde respectively. FIG. 7 excitation wavelength 455nm and emission wavelength 555 nm.
Fig. 8 shows a high performance liquid chromatogram and a mass spectrum of compound (I) prepared in example 1 of the present invention before and after addition of formaldehyde under DMSO/PBS buffer (pH 7.4, v/v 1/199).
FIG. 9 shows fluorescence imaging of formaldehyde in cervical cancer cells by the compound (I) prepared in example 1 of the present invention.
FIG. 10 shows fluorescence imaging of endogenous formaldehyde in cervical cancer cells by the compound (I) prepared in example 1 of the present invention.
Fig. 11 shows fluorescence emission spectra of compound (I) prepared in example 1 according to the present invention, added to DMSO/PBS buffer (v/v-1/199) at different pH values, and a linear relationship between fluorescence intensity and pH. Excitation wavelength 365nm and emission wavelength 455 nm.
Fig. 12 shows the change of fluorescence intensity of the probe with time in DMSO/PBS buffer (v/v ═ 1/199) at pH 4 and pH 7.4, respectively, for compound (I) prepared in example 1 according to the present invention. Excitation wavelength 365nm and emission wavelength 455 nm.
Fig. 13 is a dot plot of the change in fluorescence intensity versus the value at different pH for compound (IV) (0.5 μ M) prepared in example 1 of the present invention in DMSO/PBS buffer (pH 7.4, v/v 1/199). Excitation wavelength 365nm and emission wavelength 455 nm.
Fig. 14 is a fluorescence diagram of the selectivity results of compound (I) prepared in example 1 of the present invention in DMSO/PBS buffer (pH 7.4, v/v 1/199). 1-15 are PBS, acetaldehyde, benzaldehyde, p-nitrobenzaldehyde, p-hydroxybenzaldehyde, acetone, formic acid, glucose, glutathione, homocysteine, cysteine, sodium bisulfate, hydrogen peroxide, tert-butyl hydroperoxide and pH respectively. FIG. 14 excitation wavelength 365nm, emission wavelength 455 nm.
FIG. 15 is a photograph of an image of a compound (I) prepared in example 1 of the present invention and a commercially available Lyso-Tracker Red.
Fig. 16 is a dot plot of the change in fluorescence intensity and the value at different pH for compound (IV) (0.5 μ M) prepared in example 1 of the present invention in DMSO/PBS buffer (pH 7.4, v/v 1/199). Excitation wavelength 365nm and emission wavelength 455 nm.
Detailed Description
The invention will be further described with reference to specific examples, but the scope of the invention is not limited thereto.
Example 1
(1) Preparation of Compound (IV)
The compound (III) (0.65g,2.4mmol) and Cs2CO3(0.78g, 2.4mmol) to a solution in 10ml of anhydrous DMF was added dropwise compound (II) (0.67g,2mmol) and the mixture was taken up in N2Stirring at 40-50 deg.c overnight. The solvent was removed under high vacuum and the resulting residue was purified by column chromatography on silica using ethyl acetate/petroleum ether (v/v, 1:10) as eluent to give 0.57g of compound (IV) (yield 30%).1H NMR(500MHz,CDCl3)8.50–8.34(m,3H),7.59(dd,J=8.3,7.4Hz,1H),6.94(d,J=8.3Hz,1H),6.00(dd,J=17.5,10.9Hz,1H),5.20–5.03(m,2H),4.34(t,J=6.7Hz,2H),4.17–4.02(m,2H),2.22(dd,J=13.8,6.9Hz,1H),2.10(dt,J=14.2,7.0Hz,1H),1.67(tt,J=7.7,6.6Hz,2H),1.45(s,3H),1.41(dt,J=14.2,7.2Hz,2H),1.13(s,6H),0.95(t,J=7.4Hz,3H).13C NMR(126MHz,CDCl3)164.18,163.58,159.52,143.42,133.07,131.20,129.08,128.22,125.69,123.19,122.23,114.94,114.06,105.61,67.10,65.70,45.53,39.89,34.57,30.13,22.31,22.13,20.29,18.01,13.75.C25H30N4O3(M+H)435.2,found 435.2.
(2) Preparation of Compound (I)
Tin dichloride dihydrate (1g, 0.33mmol) was added to a round bottom flask, then thiophenol (0.11g, 1mmol) and triethylamine (0.1g, 1mmol) were added to mix in 5ml acetonitrile solvent and the mixture was stirred at 30-40 ℃ for 15min, then compound (IV) (0.1g, 0.23mmol) was added to acetonitrile solvent and stirred at 30-40 ℃ for another 12 h. The reaction was concentrated under reduced pressure and purified by column chromatography on silica gel using ethyl acetate/petroleum ether (v/v, 1: 3) as eluent to give 120mg of the final compound (I) probe DPFP.1H NMR(500MHz,CDCl3)8.47(s,3H),7.58(s,1H),7.09(d,J=8.3Hz,1H),6.07(dd,J=17.4,10.8Hz,1H),5.29–5.06(m,2H),4.56(s,1H),4.45(dd,J=15.8,8.2Hz,1H),4.30–4.00(m,2H),2.21(s,1H),1.71(ddd,J=12.7,8.6,6.7Hz,2H),1.47(dt,J=15.1,7.4Hz,2H),1.35–1.16(m,9H),0.99(t,J=7.4Hz,3H).13C NMR(126MHz,CDCl3)164.38,163.89,133.31,131.35,128.30,125.69,122.35,115.06,106.09,58.47,53.43,40.09,30.28,20.43,18.45,13.88.C25H30N4O3(M+H)409.2413,found 409.2492.
Example 2 fluorescence spectroscopy detection of compound (I) (5 μ M) at different formaldehyde concentrations.
An amount of the compound (I) prepared in example 1 was weighed out accurately, a probe stock solution having a concentration of 0.1mM was prepared using dimethylsulfoxide, 2 μ L of the solution was pipetted into 0.394mL of PBS buffer (pH 7.4), 4 μ L of different equivalent formaldehyde solutions (concentrations of final formaldehyde in the mixed solution were 0, 0.0025, 0.0075, 0.01, 0.025, 0.04, 0.05, 0.06, 0.075, 0.1, 0.15, 0.25, 0.4, 0.5, 0.6, 0.75, 1, 2, 5mM, respectively) were added, and after reacting at 37 ℃ for 3 hours, the mixture was added to a cuvette, and then the fluorescence absorption spectrum of the compound (I) was measured.
The experimental results show that the absorption of compound (I) at a wavelength of 455nm increases with increasing concentration of formaldehyde. As a result, compound (I) reacts with formaldehyde to cause a "turn-on" phenomenon, and the fluorescence spectrum is shown in FIG. 3.
Example 3 fluorescence absorbance detection of compound (I) (5 μ M) at different pH values.
An amount of the compound (I) prepared in example 1 was accurately weighed, prepared into a probe stock solution with a concentration of 0.1mM using dimethyl sulfoxide, and 2. mu.L of the solution was pipetted into 0.398mL of PBS buffers with different pH values (the final mixed solution was adjusted to pH values of 3.5 and 7.5); after 2. mu.L of the probe stock solution was aspirated using a pipette gun, added to 0.394mL of PBS buffer (pH 7.4), and then added with 4. mu.L of formaldehyde solution (to make the concentration of formaldehyde in the final mixed solution 2mM) to react at 37 ℃ for 3 hours, the mixture was added to a cuvette, and the fluorescence absorption spectrum of compound (I) was measured.
The experimental results show that at pH 3.5, compound (I) increases at a wavelength of 365nm, indicating that compound (I) generates a "turn on" phenomenon in an acidic environment. When the probe reacts with formaldehyde, the absorption of the compound (I) at the 455nm wavelength is enhanced, and a 'turn-on' phenomenon is generated, and the fluorescence spectrum is shown in figure 4.
Example 4 fluorescence spectroscopy of compound (I) (5 μ M) of the present invention under DMSO/PBS buffer (pH 7.4, v/v 1/199) with different equivalents of formaldehyde added.
An appropriate amount of the compound (I) prepared in example 1 was weighed out accurately, a probe stock solution having a concentration of 0.1mM was prepared using dimethyl sulfoxide, 2 μ L of the solution was pipetted into 0.394mL of PBS buffer (pH 7.4), 4 μ L of different equivalent amounts of formaldehyde solutions (to give final concentrations of 0, 0.0025, 0.0075, 0.01, 0.025, 0.04, 0.05, 0.06, 0.075, 0.1, 0.15, 0.25, 0.4, 0.5, 0.6, 0.75, 1, 2, 5mM, respectively) were added, and after reaction at 37 ℃ for 3 hours, the mixture was added to a 96-well plate, and then the fluorescence spectrum of the compound (I) was measured.
The experimental results show that the fluorescence intensity of compound (I) at 555nm increases with increasing concentration of formaldehyde when excited at a wavelength of 455 nm. It is shown that the reaction of compound (I) with formaldehyde generates more and more "turn-on" phenomena of compound (I). The lower limit of detection of the formaldehyde fluorescent probe is 10 mu M, R2The fluorescent spectrum is shown in figure 5, and meets the requirement of intracellular formaldehyde detection.
Example 5 compound (I) (5 μ M) of the present invention was added to 0.5mmol of formaldehyde in DMSO/PBS buffer (pH 7.4, v/v 1/199) to obtain a linear relationship of fluorescence intensity with time.
A certain amount of the compound (I) prepared in example 1 was accurately weighed, a probe stock solution with a concentration of 0.1mM was prepared using dimethyl sulfoxide, 2 μ L of the solution was pipetted into 0.394mL of PBS buffer (pH 7.4), 4 μ L of formaldehyde solution was added to make the final formaldehyde concentration 0.5mmol in the buffer, the buffer was added to a 96-well plate, the fluorescence intensity was measured every 5min at 37 ℃, the total reaction time was 3 hours, the data was counted, and a correlation curve of a linear relationship was plotted. The fluorescence excitation wavelength is 455nm, and the emission wavelength is 555 nm.
The data show that the fluorescence intensity of the formaldehyde fluorescent probe increases with time. The fluorescence spectrum is shown in FIG. 6.
Example 6 fluorescence spectroscopy detection of selective results of compound (I) (5 μ M) in the present invention under DMSO/PBS buffer (pH 7.4, v/v 1/199).
Accurately weighing a certain amount of probe (I), preparing a mother solution with the concentration of 0.1mM by using dimethyl sulfoxide, sucking 2 mu L of the probe by a pipette, adding the mother solution into 0.394mLPBS buffer solution (the pH is 7.4), respectively adding 4 mu L of formaldehyde aqueous solution (the final concentration of formaldehyde in water is 1mM) and biologically-related active small molecule aqueous solution (acetaldehyde, acetone, formic acid, 4-hydroxybenzaldehyde, 4-nitrobenzaldehyde, benzaldehyde, hydrogen peroxide, tert-butyl hydroperoxide, sodium hydrosulfide, glutathione, cysteine, homocysteine and glucose, the final concentrations of which are all 1mM), reacting at 37 ℃ for 3h, and measuring the fluorescence value of the probe. The fluorescence excitation wavelength is 455nm, and the emission wavelength is 555 nm.
The experimental result shows that the fluorescence intensity of the compound (I) is basically unchanged in the presence of other related bioactive molecules except formaldehyde, and the anti-interference capability of the compound (I) is very good, namely the specificity of the compound (I) to formaldehyde is relatively good. The fluorescence spectrum is shown in FIG. 7.
Example 7 the mechanism of the reaction of compound (I) (5 μ M) of the present invention with formaldehyde under the conditions of DMSO/PBS buffer (pH 7.4, v/v 1/199) was demonstrated.
An appropriate amount of probe (I) was weighed accurately, prepared into a 0.1mM mother solution using dimethyl sulfoxide, and 2 μ L of the solution was pipetted into 0.394ml pbs buffer (pH 7.4), and 4 μ L of an aqueous formaldehyde solution (final concentration of formaldehyde in water was 1mM) was added thereto, respectively, and reacted overnight, followed by analysis by high performance liquid chromatography. The HPLC chromatogram is shown in FIG. 8.
The experiments demonstrate that the mechanism by which we describe the reaction of compound (I) with formaldehyde is correct. Compound (I) forms an intermediate with formaldehyde and is eventually converted to compound (III), thereby signaling the effect of turn-on.
Example 8 imaging analysis of exogenous Formaldehyde in cervical cancer cells by Compound (I) of the present invention
A certain amount of the probe (I) was accurately weighed, prepared into a 10mM stock solution with dimethyl sulfoxide, and 2. mu.L of the stock solution was pipetted into 1.998 mM DMMEM medium. 1mL of the cells were added to Hela cells, incubated at 37 ℃ for 0.5h, washed twice with fresh DMEM medium, then incubated with different formaldehyde concentrations (final formaldehyde concentrations 0, 0.3mM, 0.6mM, 1mM, 2mM, respectively) for 3h, washed twice with fresh DMEM medium, and finally imaged with Olympus Fluoview FV 1200 confocal microscope. FIG. 9 is a diagram of the effect of confocal fluorescence imaging of cells: (a) PBS (pH 7.4), (b) Formaldehyde 0.3mM, (c) Formaldehyde 0.6mM, (d) Formaldehyde 1mM, or (e) Formaldehyde 2mM, and the fluorescence spectrum is shown in FIG. 9
EXAMPLE 9 imaging analysis of endogenous Formaldehyde in cervical cancer cells by Compound (I) of the present invention
An amount of probe (I) was accurately weighed, prepared into a 0.1mM stock solution using dimethyl sulfoxide, and 2. mu.L of the solution was pipetted into 0.198mL of MEM medium. Taking 1mL of NaHSO containing inhibitor3(Final NaHSO)3Concentration of 0.2mmol) or NAC (final NAC concentration of 0.2mmol) were incubated at 37 ℃ for 0.5h, respectively. The culture broth of compound (I) was then added to Hela cells, incubated at 37 ℃ for 0.5h, washed twice with DMEM medium and finally imaged with Olympus Fluoview FV 1200 confocal microscope. FIG. 10 is a diagram of the effect of confocal fluorescence imaging of cells: (a) blank probe control without inhibitor (b) NaHSO3The concentration is 0.2 mmol; (c) NAC concentration of 0.2 mmol; reference bar, 20 μm. The fluorescence spectrum is shown in FIG. 10.
The experimental result shows that the fluorescence intensity in the cell can be observed to be continuously enhanced along with the continuous increase of the concentration of the formaldehyde in the cell, which indicates that the compound (I) can detect the change of the concentration of the formaldehyde in the cell.
Example 10 fluorescence emission spectra of compound (I) (5 μ M) at different pH. The excitation wavelength was 365nm and the emission wavelength was 455 nm.
An amount of the compound (I) prepared in example 1 was accurately weighed, prepared into a probe stock solution with a concentration of 0.1mM using dimethyl sulfoxide, and 2. mu.L of the solution was pipetted into 0.398mL of PBS buffer solutions with different pH values (finally, pH values in water were 3.5 to 10), reacted at 37 ℃ for 3 hours, added to a 96-well plate, and then the fluorescence emission spectrum of the compound (I) was measured.
The experimental result shows that when the compound is excited by 365nm wavelength and the pH value is lower, the fluorescence intensity of the compound (I) at 455nm is stronger; when the pH is neutral and basic, the fluorescence intensity of compound (I) at 455nm is weak. Indicating that the probe is pH sensitive, the fluorescence spectrum is shown in FIG. 11.
Example 11 change of fluorescence intensity of the probe with time in DMSO/PBS buffer (v/v ═ 1/199), pH 4, and pH 7.4, respectively, for compound (I) of example 11.
An amount of the compound (I) prepared in example 1 was accurately weighed, a 1mM probe stock solution was prepared using dimethyl sulfoxide, 2. mu.L of the solution was pipetted into 0.398mL of PBS buffers having different pH values (final pH values were 4 and 7.4, respectively), reacted at 37 ℃ for 0.5 hour, and then added to a 96-well plate, and the fluorescence spectrum of the compound (I) was measured.
The data show that compound (I) is fully reacted at around 25 min. And at pH 4 and pH 7.4, there was a large difference in fluorescence intensity. The fluorescence spectrum is shown in FIG. 12.
Example 12 the change in fluorescence intensity of compound (IV) (5 μ M) prepared in example 1 of the present invention was plotted in the form of dots at different pH values under the conditions of DMSO/PBS buffer (pH 7.4, v/v 1/199).
An amount of the compound (IV) prepared in example 1 was accurately weighed, prepared into a probe stock solution with a concentration of 1mM using dimethyl sulfoxide, and 2. mu.L of the solution was pipetted into 0.398mL of PBS buffers with different pH values (the final pH values were adjusted from 3.5 to 9.5, respectively) and added to a 96-well plate, reacted at 37 ℃ for 3 hours, and the data was counted and plotted in a linear relationship. The fluorescence excitation wavelength is 365nm, and the emission wavelength is 455 nm.
The data show that compound (IV) is not pH sensitive, and further illustrate that the "turn on" phenomenon occurs when the amino group of compound (I) is pH sensitive. The fluorescence spectrum is shown in FIG. 13.
Example 13 fluorescence spectroscopy detection of selective results of compound (I) (5 μ M) in DMSO/PBS buffer (pH 7.4, v/v 1/199) in the present invention.
A certain amount of the compound (IV) prepared in example 1 is accurately weighed, a probe mother solution with the concentration of 1mM is prepared by dimethyl sulfoxide, 2 mu L of the probe mother solution is sucked by a pipette and added into 0.394mL, then 4 mu L of biologically relevant active small molecule aqueous solution (acetaldehyde, acetone, formic acid, 4-hydroxybenzaldehyde, 4-nitrobenzaldehyde, benzaldehyde, hydrogen peroxide, tert-butyl hydroperoxide, sodium hydrosulfide, glutathione, cysteine, homocysteine and glucose with the final concentration of 1mM) is respectively added, the reaction is carried out for 0.5h at the temperature of 37 ℃, and the fluorescence value is measured. The fluorescence excitation wavelength is 365nm, and the emission wavelength is 455 nm.
The experimental result shows that except for pH, the fluorescence intensity of the compound (I) basically has no obvious change under the existence of other related bioactive molecules, and the anti-interference capability of the compound (I) is very good, namely the specificity to the pH is relatively good. The fluorescence spectrum is shown in FIG. 14.
Example 14 cellular imaging of Compound (I) of the present invention with a commercially available Lyso-Tracker Red.
A certain amount of the probe (I) was accurately weighed, prepared into a 10mM stock solution with dimethyl sulfoxide, and 2. mu.L of the stock solution was pipetted into 1.998 mM DMMEM medium. 1mL of the culture containing compound (I) was added to Hela cells, incubated at 37 ℃ for 0.5h, washed twice with DMEM medium, then incubated with commercially available Lyso-Tracker Red (0.5. mu. mol) at 37 ℃ for 20min, washed twice with 1mL of PBS buffer (pH 7.4), and finally subjected to fluorescence imaging using an Olympus Fluoview FV 1200 confocal microscope. FIG. 15 is a diagram of the effect of confocal fluorescence imaging of cells: (a) the compound (I) has an excitation wavelength of 405nm and a receiving wavelength range of 430-480 nm, (b) a Lyso-Tracker Red, an excitation wavelength of 543nm and a receiving wavelength range of 590-640 nm; (c) a mixing channel; reference bar, 20 μm.
The experimental result shows that the compound (I) can detect the pH of lysosomes in cells, and the Fiji software is used for comparing and analyzing the fluorescence intensity in two groups of cells to obtain the Pearson correlation coefficient of 0.88, which indicates that the compound (I) can more accurately detect the pH of lysosomes. The fluorescence spectrum is shown in FIG. 15.
Example 15: the change in fluorescence intensity of compound (IV) (5 μ M) prepared in example 1 of the present invention was plotted in the form of a dot plot of the change in pH and the change in fluorescence intensity in DMSO/PBS buffer (pH 7.4, v/v 1/199).
An amount of the compound (IV) prepared in example 1 was accurately weighed, prepared into a probe stock solution with a concentration of 1mM using dimethyl sulfoxide, and 2. mu.L of the solution was pipetted into 0.398mL of PBS buffers with different pH values (the final pH values were adjusted from 3.5 to 9.5, respectively) and added to a 96-well plate, reacted at 37 ℃ for 3 hours, and the data was counted and plotted in a linear relationship. The fluorescence excitation wavelength is 365nm, and the emission wavelength is 455 nm.
The data show that compound (IV) is not pH sensitive, and further illustrate that the "turn on" phenomenon occurs when the amino group of compound (I) is pH sensitive. The fluorescence spectrum is shown in FIG. 16.
Comparative example 1
The following compounds (1) are disclosed in the references (x.f.wu, l.h.li, w.shi, q.y.gong, x.h.li, and h.m.ma, Sensitive and selective ratio strategies for Probes for Detection of intracellular genes Monoamine oxidase a, anal.chem.,2016,88, 1440):
the compound (1) is used as a fluorescent probe, can only realize single monoamine oxidase detection in cells, and cannot realize dual-function detection of pH and formaldehyde.
Comparative example 2
To examine the uniqueness of the probe of the present invention, the present invention also examined whether the compound (2) having a structure similar to the probe can be used for pH detection:
the replacement of compound (IV) in comparative example 2 with compound (2) showed that compound (2) was not sensitive to pH under the same assay conditions.
Claims (5)
3. the method of claim 2, wherein: the preparation method specifically comprises the following steps: compound (III), Cs2CO3Mixing the materials in an amount of 1: 1-1.5 in anhydrous DMF, dropwise adding a compound (II), and adding the mixture in N2Stirring overnight at 40-50 ℃ under protection; the solvent was removed under reduced pressure, and the obtained residue was purified by silica column chromatography to obtain compound (IV).
5. the use of claim 4, wherein: the application specifically comprises the following steps: adding tin dichloride dihydrate, triethylamine and thiophenol into an acetonitrile solvent according to the mass ratio of 1: 2-3.5, stirring at 30-40 ℃ for 15-30 min, and then adding a compound (IV), wherein the mass ratio of the compound (IV) to the tin dichloride dihydrate is 0.5-1: 1, continuously stirring for 12-14 h at the temperature of 30-40 ℃; the reaction product was concentrated under reduced pressure and purified by silica column chromatography to obtain compound (I).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810582599.2A CN109824592B (en) | 2018-06-07 | 2018-06-07 | Dual-functional fluorescent probe intermediate for detecting formaldehyde and pH, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810582599.2A CN109824592B (en) | 2018-06-07 | 2018-06-07 | Dual-functional fluorescent probe intermediate for detecting formaldehyde and pH, and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109824592A CN109824592A (en) | 2019-05-31 |
CN109824592B true CN109824592B (en) | 2020-10-27 |
Family
ID=66858714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810582599.2A Active CN109824592B (en) | 2018-06-07 | 2018-06-07 | Dual-functional fluorescent probe intermediate for detecting formaldehyde and pH, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109824592B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110372590B (en) * | 2019-07-29 | 2021-10-26 | 济南大学 | Fluorescent probe for detecting pH of lysosome and preparation method and application thereof |
CN114149369B (en) * | 2021-12-14 | 2024-02-06 | 河南省农业科学院农业质量标准与检测技术研究所 | Fluorescent probe FAL1 for formaldehyde and pH dual-function detection, and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105372217A (en) * | 2015-11-17 | 2016-03-02 | 济南大学 | Formaldehyde fluorescent probe, and preparation method and application thereof |
CN106518762A (en) * | 2016-11-02 | 2017-03-22 | 济南大学 | Fluorescent probe for detecting formaldehyde in cell endoplasmic reticulums |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100501370C (en) * | 2007-03-19 | 2009-06-17 | 浙江工业大学 | Monoamine oxidase activity fluorescent detecting method |
CN105924394B (en) * | 2016-05-20 | 2018-08-21 | 浙江工业大学 | A kind of two-photon formaldehyde fluorescence probe and its preparation and application |
CN107501245B (en) * | 2017-08-02 | 2020-02-21 | 浙江工业大学 | Mitochondrion-targeted double-signal turn-on formaldehyde fluorescent nano probe and preparation and application thereof |
-
2018
- 2018-06-07 CN CN201810582599.2A patent/CN109824592B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105372217A (en) * | 2015-11-17 | 2016-03-02 | 济南大学 | Formaldehyde fluorescent probe, and preparation method and application thereof |
CN106518762A (en) * | 2016-11-02 | 2017-03-22 | 济南大学 | Fluorescent probe for detecting formaldehyde in cell endoplasmic reticulums |
Also Published As
Publication number | Publication date |
---|---|
CN109824592A (en) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105924394A (en) | Two-photon formaldehyde fluorescent probe and preparation and application thereof | |
CN108069966B (en) | Small molecular fluorescent probe for SNAP protein labeling and synthetic method and application thereof | |
CN108727265B (en) | Dual-functional fluorescent probe for detecting formaldehyde and pH (potential of hydrogen), and preparation method and application thereof | |
CN109735328A (en) | A kind of fluorescence probe and its preparation method and application detecting intracellular hydrogen sulfide | |
CN109438326B (en) | Fluorescent probe for detecting carboxylesterase, preparation method thereof and special detection kit | |
CN109836394B (en) | Near-infrared fluorescent probe for identifying hydrogen sulfide and preparation method and application thereof | |
Huang et al. | A novel near-infrared fluorescent hydrogen sulfide probe for live cell and tissue imaging | |
CN113801105B (en) | Mitochondrion targeted peroxynitrite/bisulfite dual-response fluorescent probe | |
Zhu et al. | A novel highly sensitive fluorescent probe for bioimaging biothiols and its applications in distinguishing cancer cells from normal cells | |
CN108752275B (en) | pH fluorescent probe and preparation method and application thereof | |
CN109824592B (en) | Dual-functional fluorescent probe intermediate for detecting formaldehyde and pH, and preparation method and application thereof | |
CN109651249A (en) | A kind of fluorescence probe detecting endocytoplasmic reticulum cysteine and its synthesis and application | |
CN109180716B (en) | Multi-signal ratio type distinguishing detection H2O2And H2Design, synthesis and application of fluorescent probe of S | |
CN108690011A (en) | A kind of fluorescence probe of detection cysteine | |
CN108640939A (en) | A kind of rhodamine base H2O2Fluorescence probe and its synthetic method | |
CN109400563B (en) | Hypochlorous acid fluorescent probe and preparation method and application thereof | |
Cao et al. | A two-photon lysosome-targeted probe for endogenous formaldehyde in living cells | |
CN108752373A (en) | A kind of fluorescence probe identifying hydrogen peroxide based on benzene boron ester | |
CN110642857B (en) | Difunctional fluorescent probe for detecting viscosity and pH, and preparation and application thereof | |
CN114105927B (en) | Construction of benzopyran nitrile fluorescent molecular probe and in-vitro diagnosis application thereof | |
CN110878085B (en) | Rapid high-selectivity hypobromous acid fluorescent probe, preparation method and application | |
CN109021000A (en) | A kind of fluorescence probe, synthetic method and application detecting hydrogen peroxide | |
Gu et al. | Development of a highly selective H 2 S fluorescent probe and its application to evaluate CSE inhibitors | |
CN109485627B (en) | Coumarin derivative, synthesis method thereof and application of coumarin derivative in detection of hydrogen sulfide | |
CN115594672A (en) | Methylene blue near-infrared fluorescent probe and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |